Literature DB >> 7083142

Hodgkin's disease in Western India: review of 1082 cases.

G V Talvalkar, M B Sampat, P Gangadharan.   

Abstract

Hodgkin's disease (HD) had a low overall incidence rate in Bombay when compared to western countries. However, the incidence rate in childhood was quite high. Review of 1082 cases of Hodgkin's disease recorded at the Tata Memorial Hospital, Bombay. India during a period of 35 years showed that mixed cellularity, with 54% of the total, was the most frequent histologic subtype and this, together with lymphocyte depleted type formed 68% of all HD. The nodular sclerosis type formed only 9%. A bimodal character of the age pattern with a young age peak in the second decade of life, a male preponderance, a high incidence in childhood, and the predominance of low survival types, are the major features of the disease in India. The current data, which are the largest series reported from Bombay and other parts of India, indicate that the type-I pattern as described by Correa and O'Connor may be the characteristic feature of the Hodgkin's disease in India.

Entities:  

Mesh:

Year:  1982        PMID: 7083142     DOI: 10.1002/1097-0142(19820715)50:2<353::aid-cncr2820500232>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Clinico-pathologic profile of Hodgkin's lymphoma in a rural medical college.

Authors:  Bidyut Krishna Goswami; Supriya Sarkar; Sudipta Chakrabarti; Srikrishna Mondal; Amitabha Roy; Asit R Deb
Journal:  Indian J Hematol Blood Transfus       Date:  2009-01-11       Impact factor: 0.900

2.  Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India.

Authors:  Dinesh Bhurani; Reena Nair; Senthil Rajappa; Suparna Ajit Rao; Nithya Sridharan; Rakesh Reddy Boya; Ganapathi S Raman; Hari Menon; Arun Seshachalam; Ramesh Nimmagadda
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

3.  Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence.

Authors:  Arun Seshachalam; Shashidhar V Karpurmath; Krishnakumar Rathnam; S Ganapathi Raman; Murugesan Janarthinakani; Krishna Prasad; Channappa Patil; Parameswaran Anoop; Neelesh Reddy; Satish Kumar Anumula; Sirigeri Prabhakar Roopa; Krishna Reddy Golamari; Madhav Danthala; Prasad Gunari; Basawantrao Malipatil; Bharath Rangarajan; Karthik S Udupa; Manjunath Nandennavar; Kesavan Niraimathi; Hemant Deepak Shewade
Journal:  J Glob Oncol       Date:  2019-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.